Aug 29 2013
Lucid, Inc. , d/b/a Caliber Imaging & Diagnostics (Caliber I.D.), a leader in noninvasive optical biopsies of skin and manufacturer of VivaScope® confocal imaging systems, has entered into a strategic advisory agreement with H.C. Wainwright & Co., LLC, designed to benefit the growth of Caliber I.D. as it continues to develop its business through a variety of channels.
As part of the agreement, H.C. Wainwright will serve as an advisor to Caliber I.D. by helping to identify, originate and develop potential strategic partnerships, assisting with M&A transactions, and helping to raise capital. The agreement additionally includes but is not limited to new product procurement, generating additional distribution channels and assessing collaborations to promote Caliber I.D.'s business.
Caliber I.D.'s current integrated platform of VivaScope® products includes non-invasive cellular imaging systems that enable physicians to diagnose skin disease, including basal cell carcinoma, melanoma, and inflammatory disorders, in realtime with an optical biopsy as compared with a traditional invasive or surgical biopsy. Additional applications of the technology include therapeutic monitoring, claims validation for cosmeceuticals and pharmaceuticals, and intrasurgical imaging of living tissues.
Additional information regarding this agreement can be found in Caliber Imaging & Diagnostics' Form 8-K filed with the Securities and Exchange Commission on August 27, 2013.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
Press release avilable from http://www.prnewswire.com/